Status:
COMPLETED
Dose Ranging Study in Healthy Methadone Maintenance Subjects
Lead Sponsor:
Bausch Health Americas, Inc.
Conditions:
Adult
Eligibility:
All Genders
18-65 years
Phase:
PHASE1
Brief Summary
To assess the effect of a single oral dose of MOA-728, an investigational drug, on the oral-cecal transit time in subjects who are taking methadone.
Eligibility Criteria
Inclusion
- Men or nonlactating and nonpregnant women, aged 18 to 65 years
- Healthy as determined by the investigator on the basis of medical history, physical examination, clinical laboratory test results, vital signs, and 12-lead electrocardiogram
Exclusion
Key Trial Info
Start Date :
June 1 2006
Trial Type :
INTERVENTIONAL
End Date :
October 1 2006
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT00387491
Start Date
June 1 2006
End Date
October 1 2006
Last Update
November 25 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lenexa, Kansas, United States, 66219